<DOC>
	<DOCNO>NCT02943785</DOCNO>
	<brief_summary>When upper chamber person 's heart receive irregular electrical signal cause abnormal rhythm heart beat . This call atrial fibrillation . Atrial fibrillation increase chance heart attack stroke . Some patient also get new heart valves use catheter . Often doctor give patient medicine call vitamin K antagonist ( VKA ) , consider standard care . This study see edoxaban compare VKA patient get new heart valve use catheter . The study compare two drug three year heart valve replacement , look drug 's overall side effect ( call adverse event ) major bleeding .</brief_summary>
	<brief_title>Edoxaban Compared Standard Care After Heart Valve Replacement Using Catheter Patients With Atrial Fibrillation ( ENVISAGE-TAVI AF )</brief_title>
	<detailed_description>Use Edoxaban patient atrial fibrillation ( AF ) indication chronic oral anticoagulation ( OAC ) transcatheter aortic valve implantation ( TAVI ) Objective : - To assess effect Edoxaban versus vitamin K antagonist ( VKA ) net adverse clinical event ( NACE ) , i.e. , composite all-cause death , myocardial infarction ( MI ) , ischemic stroke , systemic thromboembolism ( SEE ) , valve thrombosis , major bleeding ( International Society Thrombosis Haemostasis [ ISTH ] definition ) . - To assess effect Edoxaban versus VKA major bleeding ( ISTH definition ) .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Edoxaban</mesh_term>
	<mesh_term>Phenprocoumon</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Acenocoumarol</mesh_term>
	<criteria>Criteria : Meets protocolspecified criterion qualification contraception Is willing able comply restriction relate food , drink medication Voluntarily consent participate provide write informed consent prior protocolspecific procedure Has history current use overthecounter medication , dietary supplement , drug ( include nicotine alcohol ) outside protocolspecified parameter Has sign , symptom history condition , per protocol opinion investigator , might compromise : 1. safety wellbeing participant study staff 2. safety wellbeing participant 's offspring ( pregnancy breastfeed ) 3. analysis result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Transcatheter Aortic Valve Implantation -- TAVI</keyword>
	<keyword>Anticoagulation</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>ENVISAGE-TAVI-AF</keyword>
</DOC>